ApoRepair Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

ApoRepair General Information

Description

Developer of a first-in-class therapeutic peptide administered during coronary reperfusion procedures designed to reduce procedure-related complications and improve survival after heart attacks. The company is advancing a drug candidate intended to be given alongside standard interventions such as artery reopening techniques, with the aim of limiting subsequent cardiac damage, and lowering long-term morbidity enabling myocardial infarction patients to address major public health challenge in cardiovascular disease.

Contact Information

Website
www.aporepair.fr
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Innovation Hall, Cambacérès Business Park
  • 10 Place Françoise Héritier
  • 34000 Montpellier
  • France
Primary Industry
Biotechnology
Vertical(s)
LOHAS & Wellness, HealthTech, Life Sciences
Corporate Office
  • Innovation Hall, Cambacérès Business Park
  • 10 Place Françoise Héritier
  • 34000 Montpellier
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ApoRepair Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Spin-Off Completed Generating Revenue
To view ApoRepair’s complete valuation and funding history, request access »

ApoRepair Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

ApoRepair Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026219974-A1 Combination of bivalirudin and cardioprotective peptides Pending 17-Apr-2025

ApoRepair Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ApoRepair Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Boost Invest MedVallée Accelerator/Incubator
Business & Innovation Center Accelerator/Incubator
To view ApoRepair’s complete investors history, request access »

Ready to get started?

Request a free trial

ApoRepair FAQs

  • When was ApoRepair founded?

    ApoRepair was founded in 2023.

  • Where is ApoRepair headquartered?

    ApoRepair is headquartered in Montpellier, France.

  • What is the size of ApoRepair?

    ApoRepair has 5 total employees.

  • What industry is ApoRepair in?

    ApoRepair’s primary industry is Biotechnology.

  • Is ApoRepair a private or public company?

    ApoRepair is a Private company.

  • What is ApoRepair’s current revenue?

    The current revenue for ApoRepair is .

  • Who are ApoRepair’s investors?

    Boost Invest MedVallée and Business & Innovation Center have invested in ApoRepair.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process